Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
H3 histone pseudogene 39 (H3P39, also known as p49) is categorized as a **pseudogene** for a histone H3 family member. Pseudogenes are **DNA sequences resembling known genes that are non-functional**; they typically arise either through duplication or retrotransposition events, but they do not encode a functional protein product[4]. The H3 histone family has a large number of such processed pseudogenes, which are generally not transcribed into protein or functional RNA and lack evidence for a biological or therapeutic role in humans. Thus, H3P39 is not a valid receptor, enzyme, transporter, transcription factor, or otherwise actionable molecular target for therapy or drug development.\n\n**Clarification and Potential Issues:**\n- H3 histone pseudogene 39 is *not a canonical histone H3 variant*: Functional histone H3 proteins (such as H3.1, H3.2, H3.3) are expressed from specific genes and play central roles in chromatin structure and gene regulation[1][2][3]. Only the protein-coding histone genes and their functional variants participate in biological processes and serve as drug or biomarker targets.\n- There is **no evidence that H3P39/p49 is expressed or functional or that it represents a therapeutic target**.\n- The name "p49" is used ambiguously in the literature for other entirely unrelated proteins, so this alias may introduce further confusion. If "p49" in a given context refers to something else (such as a viral protein or another cellular factor), that would need explicit clarification.\n- If you are interested in histone H3 variants as genuine targets, the **functional forms are H3.1, H3.2, and H3.3**, especially H3.3, which is linked to chromatin regulation and certain cancers[1][2].\n\n**Conclusion:**\n**H3 histone pseudogene 39 (H3P39/p49) is not a functional target, but a non-functional pseudogene and is not used in drug development, biomarker selection, or disease targeting.** The designation should generally not be used for structured therapeutic target information[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on H3 histone pseudogene 39 (H3P39).